|4Jan 3, 4:10 PM ET

Charlton Ralph William III 4

4 · SPRUCE BIOSCIENCES, INC. · Filed Jan 3, 2024

Insider Transaction Report

Form 4
Period: 2023-12-29
Charlton Ralph William III
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2023-12-29$0.98/sh+9,361$9,15055,373 total
Footnotes (1)
  • [F1]Shares acquired by the Reporting Person pursuant to the Issuer's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The Reporting Person acquired the maximum shares allowable pursuant to Section 423 of the Internal Revenue Code.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION